EGFR amplification indicated poor prognosis in EGFR ‐mutated lung cancer with leptomeningeal metastases

ConclusionEGFR amplification indicated poor prognosis in EGFR-mutated lung cancer with leptomeningeal metastases, providing a novel pathogenesis and treatment direction of these patients.

Source: The Clinical Respiratory Journal - February 2, 2024 Category: Respiratory Medicine Authors: Di Geng, Ruina Niu, Jinghong Li, Sanxing Guo, Qianqian Guo, Siyuan Huang, Yurong Wang Tags: ORIGINAL ARTICLE Source Type: research